You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radium Ra 223 dichloride

Showing 1 - 25 of 1,687
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Prostate Cancer Trial in United States (Radium dichloride, PET Scan)

Recruiting
  • Prostate Cancer
  • Radium dichloride
  • PET Scan
  • Aurora, Colorado
  • +8 more
Sep 15, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +21 more
Dec 2, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +26 more
Jan 25, 2023

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Prostate Cancer Metastatic to Bone Trial in Salt Lake City (Radium Ra 223 Dichloride, Radiation)

Active, not recruiting
  • Prostate Cancer Metastatic to Bone
  • Radium Ra 223 Dichloride
  • Radiation
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Sep 20, 2021

Breast Cancer Trial in Houston (Ra-223 dichloride, Denosumab, Hormone Therapy)

Completed
Has Results
  • Breast Cancer
  • Ra-223 dichloride
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 5, 2021

Overall Survival and Effectiveness Predictors for mCRPCReal Life

Completed
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    Many Locations
Nov 1, 2021

Prostate Cancer Trial in Salt Lake City (Radium Ra 223 Dichloride, Enzalutamide)

Completed
Has Results
  • Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 5, 2020

Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United

Active, not recruiting
  • Prostate Carcinoma Metastatic to the Bone
  • +2 more
  • Birmingham, Alabama
  • +5 more
Feb 10, 2021

How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

Recruiting
  • Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Taiwan
    Many locations
Aug 19, 2022

Learn More About How Radium-223 is Being Used With Other

Active, not recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium 223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Denmark
  • +2 more
Jan 16, 2023

Learn More About How Radium-223 Affects Quality of Life of

Recruiting
  • Prostate Cancer
  • Radium-223-dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Colombia
    Many Locations
Jan 19, 2023

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Patients and Other Factors Which May Contribute to Survival

Completed
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Whippany, New Jersey
    Bayer Flatiron Xofigo Registry database
Mar 17, 2022

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

Prostate Cancer Trial in Houston (Alpharadin)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 16, 2022

Bone Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Linz, Oberösterreich, Austria
  • +15 more
Aug 24, 2022

Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223 dichloride (Xofigo, BAY 88-8223)
  • Multiple Locations, Japan
    (unnamed)
Feb 2, 2023

Prostate Cancer Trial in Montreal (radium-223 dichloride)

Completed
  • Prostate Cancer
  • radium-223 dichloride
  • Montreal, Quebec, Canada
    Jewish General Hospital
Sep 20, 2021

Radium-223 Treated Castration Resistant Prostate Cancer Bone

Completed
  • Castration-Resistant Prostatic Cancer
  • Radium-223 dichloride, (Xofigo, BAY88-8223)
  • Multiple Locations, Germany
    (unnamed)
Nov 1, 2021

Healthcare Services and Way Disease is Cared for in Canadian

Completed
  • Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Canada
    Multiple Locations
Jun 22, 2022